Is Omnipod available on the NHS?

Diabetes Tech Discussion Guide: Access, Eligibility, & Conversation Tool

Accessing diabetes management technology – an insulin pump, a continuous glucose monitoring system, or a hybrid closed loop system can feel complicated and unclear. This tool aims to answer some common questions and to support you in discussing your personal situation with your diabetes care team.

 

1- How can I get an insulin pump on the NHS?

Type 1 diabetes

If a diabetes specialist team believes that someone meets the clinical criteria for a pump and would benefit from pump therapy, NHS funding must be made available.
If you are not currently under a diabetes specialist team, or it has been more than a year since your last hospital appointment, ask your GP for a referral.

England, Wales and Northern Ireland 

The National Institute of Health and Care Excellence (NICE) published a mandatory Technology Appraisal of Continuous Subcutaneous Insulin Infusion (CSII, the technical name for insulin pump therapy) in 2008. There are different criteria for children aged younger than 12 and people aged 12 and up. A summary* is online here.

Scotland 

The Scottish Intercollegiate Guidelines Network published a national guideline on the management of type 1 diabetes in 2010. The full guideline document is online here (see pages 33–34 for information on CSII).

*Please note that the ‘Further information and support’ list on the back cover of that summary is out of date – see the list at the end of this page instead.

Type 2 diabetes

Across the UK, insulin pump therapy is uncommon for people living with type 2 diabetes and NHS funding is possible only if a diabetes specialist team makes a special funding request, as there is no formal policy.

Omnipod 5 is not currently approved for use with type 2 diabetes outside the United States of America.

2- How can I get a continuous glucose sensor (CGM/sensor) on the NHS?

Glucose sensors, including FreeStyle Libre 2 Plus and Dexcom ONE+, are widely available on prescription from your GP, to people with type 1 diabetes across the UK.

doctor + podder doctor + podder

However, unlike insulin pump therapy, there are no mandatory national policies regarding access to glucose sensors. Some people living with type 2 diabetes can also access sensors - dependent on local policies and access.

  • If you are not able to get a sensor on prescription from your GP, ask the diabetes specialist team to write to the GP regarding your need for a sensor. 
    • If you are not currently under a diabetes specialist team, or it has been more than a year since your last hospital appointment, you can ask your GP for a referral. 
  • If you already have a sensor and you are seeking access to a different sensor, you can ask your diabetes specialist team about local sensor funding policies. Otherwise, if you are financially in a position to do so, you may be able to self-fund your own sensor.
     

For more information, please see the NICE Guidelines 17 and 18.

3- How can I get a Hybrid Closed Loop (HCL) system on the NHS?

What is a HCL System?

A HCL system contains two parts, an insulin pump and a compatible glucose sensor (called a CGM or sensor). However what makes HCL unique, is that it includes one key differentiating factor: an algorithm. The algorithm will automatically adjust how much insulin the pump will deliver, based on the glucose sensor data it receives. For a HCL system to work, the sensor, pump, and algorithm must be able to ‘talk’ to one another for the algorithm to work automatically (and allow you to go about your day!). There are a few different insulin pumps and sensors that work compatibly to make a HCL system. If you decide to try a hybrid closed loop system, we believe it is your right to choose which technology you use as to make up that system. Opposite, we’ve supplied some resources to help you understand the guidance on access and eligibility to HCL systems in your region:

England, Wales and Northern Ireland
In England, if a diabetes specialist team believes that someone meets the clinical criteria for an HCL system and would benefit from an HCL system, NHS funding must be made available. If you are not currently under a diabetes specialist team, or it has been more than a year since your last hospital appointment, ask your GP for a referral.
All HCL systems are available on the National Framework for the UK for Insulin Pumps, Continuous Glucose Monitoring, and Associated Products.
NICE published a mandatory Technology Appraisal of HCL systems for people living with T1D in December 2023.
A summary of the national clinical criteria published by NICE for access to HCL systems is available here.

Scotland
The Scottish Health Technologies Group (SHTG) released an SHTG recommendation on Closed Loop Systems and the Artificial Pancreas for Type I Diabetes Mellitus (T1DM) in January 2022. A summary and a link to the full recommendation document are online here. Scottish Health Boards have implemented this Recommendation through the ANIA programme.

2col podders tech guide2 1200x900x96 2col podders tech guide2 1200x900x96
activity black icon

Next Steps

Preparing to share with the diabetes specialist team

Starting 3–4 weeks before your next diabetes appointment

Starting 2–3 weeks before the appointment

A few days before the appointment

During the appointment

At the end of the appointment

After the appointment

icon information | Simplify life Omnipod®

Further information and support

UK-WIDE

ENGLAND

SCOTLAND

NORTHERN IRELAND

2col podder tech guide3 1200x900x96 2col podder tech guide3 1200x900x96

Talk to an Omnipod® Specialist

Still have more questions about the Omnipod® System? Enter your information below and one of our Omnipod® Specialists will call you in 24-48 hours for a one-to-one chat. Or you can call us direct at 0800 011 6132* (option 4) or +44 20 3887 1709 (option 4) if calling from abroad.

Jessica Sparks Lilley (pediatric endocrinologist)

Article by

Jessica Sparks Lilley (pediatric endocrinologist)

Last updated 25/03/2026

Jessica Sparks Lilley is a pediatric endocrinologist and the senior manager of field medical affairs at Insulet Corporation. She was drawn to her career field by beloved family members who were diagnosed in early childhood with T1DM. She trained at Vanderbilt Children’s Hospital and the Children’s Hospital of Philadelphia. Her passion for her home state drew her to practice in rural Mississippi for 13 years, first building an academic satellite clinic then a new multispecialty clinic with far-flung outreach, each from the ground up. She had a regular column in Medscape, “It’s a Small World,” on a variety of topics in pediatric endocrinology. Her research focused on diabetes numeracy and inherited lipid disorders. She has actively supported Breakthrough T1D and the Diabetes Foundation of Mississippi. She is passionate about expanding access of diabetes technology to people living with diabetes and joined Insulet in 2024 after seeing the transformative impact of automated insulin delivery in her patients and loved ones.

Related Articles

​​​Insulin Pumps, Explained

Get a clear overview of insulin pumps—from traditional tubed models to patch pumps, closed-loop systems, and automated insulin delivery (AID) technologies.   

What Is Insulin Pod Therapy?

Discover the advantages of Insulin Pod Therapy with Omnipod®. Learn how this tubeless insulin pump can enhance your diabetes management by offering the same benefits as traditional pump therapy, but with more freedom and…

Hybrid Closed Loop (HCL), explained.

Explore how Automated Insulin Delivery (AID) systems use smart algorithms to fine-tune insulin dosing based on live glucose data. 

Other topics